Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Expensive Performer
590.3000 -6.75 (-1.13%)
NSE May 22, 2025 09:27 AM
Volume: 161.8K
 

logo
Laurus Labs Ltd.
03 Dec 2016
590.30
-1.13%
Angel Broking
Laurus Labs is a Hyderabad based company engaged in manufacturing of Active Pharma Ingredients (API). Company derives 80% of its revenues from exports while rest comes from the domestic markets. Its client base features companies like Cipla, Natco, Mylan, etc. API is its largest segment which contributes 92% of the revenues while rest 8% comes from its Synthesis and Ingredients business. Investment rationale 1) Company operates its API business model with a niche focus on select therapeutic segments. This makes it a specialist API manufacturer in a few therapeutic segments. 2) Laurus intends to enter in the US market with its...
Laurus Labs Ltd. has gained 30.19% in the last 1 Year
More from Laurus Labs Ltd.
Recommended